Biomunex, Institut Curie collaborate on solid tumor therapy
Biomunex Pharmaceuticals and Institut Curie are collaborating to develop a breakthrough immunotherapy drug candidate for the treatment of hematological malignancies and solid tumors based on Biomunex's proprietary Bixab technology. Read More
Bruker launches new timsTOF-based MALDI PharmaPulse system
Bruker Corporation has launched its trapped ion mobility spectronomy time-of-flight (timsTOF) matrix-assisted laser desorption/ionization (MALDI) PharmaPulse system, a new solution for unbiased, deep, high-throughput screening (HTS) and ultra HTS based on label-free mass spectrometry, at the SLAS 2022 International Conference and Exhibition. Read More
Twist Bioscience, Eleven Therapeutics create replicon for antiviral development
Twist Bioscience and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication and antiviral drug screening as well as vaccine and therapeutic development. Read More
Agilent highlights integrated automation solutions at SLAS 2022
Agilent integrated automation solutions highlighted several new innovations, including the BioTek BioSpa Live Cell Analysis System, at the Society for Laboratory Automation and Screening (SLAS) 2022 conference. Read More
Bruker expands nanoflow consumables portfolio
Bruker Corporation has acquired PepSep, a company specializing in nanoflow liquid chromatography columns, specialty emitters, and components to optimize nanoflow proteomics workflows, which are extensively used in Bruker's nanoElute ultra high-performance liquid chromatography system. Read More
Gene expression profile could enable rapid ID of antitumor immune cells
National Institutes of Health researchers, led by Dr. Steven Rosenberg, PhD, at the National Cancer Institute, have found unique expression profiles in 50 genes that help identify rare antitumor lymphocytes that can infiltrate and help defeat metastatic solid epithelial tumors. Read More
NCCN joins call to close care gap
The National Comprehensive Cancer Network (NCCN) is joining organizations worldwide to draw attention to widespread inequities in cancer care and to work to address them. Read More
Amgen, Plexium announce drug discovery collaboration
Amgen and Plexium have entered into an exclusive worldwide multiyear research collaboration and license agreement to identify novel, targeted protein degradation therapeutics toward historically challenging drug targets. Read More
Novavax COVID-19 vaccine approved in Great Britain
Novavax announced that the Medicines and Healthcare products Regulatory Agency has granted conditional marketing authorization for its Nuvaxovid COVID-19 vaccine for active immunization in individuals 18 years of age and older in Great Britain. The vaccine, also known as NVX-CoV2373, is the first protein-based vaccine to be authorized for use in Great Britain. Read More
Thermo Fisher Scientific unveils Nicolet RaptIR FTIR microscope
Thermo Fisher has released the Thermo Scientific Nicolet RaptIR Fourier transform infrared (FTIR) microscope. It enables users of varying experience levels to quickly locate areas of interest, collect high-spatial resolution visual and infrared data, and generate accurate results with minimal time and effort. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
